Kirk Clark

2.8k total citations · 1 hit paper
16 papers, 1.5k citations indexed

About

Kirk Clark is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Kirk Clark has authored 16 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 2 papers in Organic Chemistry and 2 papers in Oncology. Recurrent topics in Kirk Clark's work include Enzyme Production and Characterization (2 papers), RNA Interference and Gene Delivery (2 papers) and Protease and Inhibitor Mechanisms (2 papers). Kirk Clark is often cited by papers focused on Enzyme Production and Characterization (2 papers), RNA Interference and Gene Delivery (2 papers) and Protease and Inhibitor Mechanisms (2 papers). Kirk Clark collaborates with scholars based in United States, Switzerland and Italy. Kirk Clark's co-authors include S.K. Burley, E.D. Halay, Eseng Lai, Paul M. Steed, Daniel LaSala, William C. Boyar, John M. Grange, Xiaoling Xie, Fong Shu and Steven Dayan and has published in prestigious journals such as Nature, Cancer Research and The FASEB Journal.

In The Last Decade

Kirk Clark

16 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5

1993 1.1k citations Kirk Clark, E.D. Halay et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kirk Clark United States	10	1.3k	237	126	119	119	16	1.5k
Harry Wischnewski Switzerland	15	1.7k 1.3×	92 0.4×	158 1.3×	35 0.3×	65 0.5×	20	1.9k
Daniel E. Eyler United States	10	1.7k 1.3×	116 0.5×	108 0.9×	38 0.3×	131 1.1×	15	1.9k
Andrew P. VanDemark United States	23	1.7k 1.3×	100 0.4×	115 0.9×	59 0.5×	188 1.6×	42	2.0k
Yorick Post Netherlands	8	1.3k 1.0×	232 1.0×	48 0.4×	136 1.1×	240 2.0×	16	1.6k
G. Sebastiaan Winkler United Kingdom	28	2.4k 1.9×	214 0.9×	179 1.4×	91 0.8×	347 2.9×	53	2.8k
Brigitte Boldyreff Germany	25	1.8k 1.4×	260 1.1×	166 1.3×	93 0.8×	355 3.0×	51	2.2k
Eva R. Hoffmann Denmark	29	1.4k 1.1×	398 1.7×	293 2.3×	72 0.6×	70 0.6×	69	2.2k
Adam Burton United Kingdom	14	1.3k 1.0×	162 0.7×	214 1.7×	54 0.5×	87 0.7×	18	1.6k
Koji Sagane Japan	19	1.2k 1.0×	144 0.6×	91 0.7×	48 0.4×	250 2.1×	27	1.9k
Paul van den IJssel United Kingdom	12	987 0.8×	170 0.7×	73 0.6×	47 0.4×	168 1.4×	14	1.3k

Countries citing papers authored by Kirk Clark

Since Specialization

Citations

This map shows the geographic impact of Kirk Clark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirk Clark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirk Clark more than expected).

Fields of papers citing papers by Kirk Clark

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kirk Clark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirk Clark. The network helps show where Kirk Clark may publish in the future.

Co-authorship network of co-authors of Kirk Clark

This figure shows the co-authorship network connecting the top 25 collaborators of Kirk Clark. A scholar is included among the top collaborators of Kirk Clark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirk Clark. Kirk Clark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Romanowski, M.J., Kirk Clark, Erik L. Meredith, et al.. (2018). Full-length myocilin protein is purified from mammalian cells as a dimer. Protein Expression and Purification. 147. 38–48. 4 indexed citations

Hu, Tiancen, Elizabeth R. Sprague, Michelle Fodor, et al.. (2017). The impact of structural biology in medicine illustrated with four case studies. Journal of Molecular Medicine. 96(1). 9–19. 7 indexed citations

Hu, Qiying, Martin Allan, Roberto Adamo, et al.. (2013). Synthesis of a well-defined glycoconjugate vaccine by a tyrosine-selective conjugation strategy. Chemical Science. 4(10). 3827–3827. 100 indexed citations

Meetze, Kristan, et al.. (2012). 414 The Anti-tumor Activity of the ERBB3 Inhibitory Antibody AV-203 in Patient Derived Tumor Explant Models. European Journal of Cancer. 48. 126–126. 2 indexed citations

Huet, Heather, Alwin G. Schuller, Jing Li, et al.. (2012). Abstract 3853: TAS266, a novel tetrameric nanobody agonist targeting death receptor 5 (DR5), elicits superior antitumor efficacy than conventional DR5-targeted approaches. Cancer Research. 72(8_Supplement). 3853–3853. 7 indexed citations

Kulathila, Raviraj, David R. Sage, Susan Cornell-Kennon, et al.. (2008). The structure of the BIR3 domain of cIAP1 in complex with the N-terminal peptides of SMAC and caspase-9. Acta Crystallographica Section D Biological Crystallography. 65(1). 58–66. 28 indexed citations

Dayan, Steven, et al.. (2004). Altering First Impressions After Facial Plastic Surgery. Aesthetic Plastic Surgery. 28(5). 301–306. 31 indexed citations

Greenspan, Paul D., Kirk Clark, Scott D. Cowen, et al.. (2003). N-Arylaminonitriles as bioavailable peptidomimetic inhibitors of cathepsin B. Bioorganic & Medicinal Chemistry Letters. 13(22). 4121–4124. 22 indexed citations

Kulathila, Raviraj, Kirk Clark, Paula Savage, et al.. (2002). Expression, purification and characterization of the monomeric and dimeric forms of soluble bovine endothelin converting enzyme-1a. Clinical Science. 103(s2002). 94S–97S. 3 indexed citations

10.

Clark, Kirk, et al.. (2001). Lack of evidence for muscarinic type 2 receptor modulation of the human nasonasal reflex. Journal of Allergy and Clinical Immunology. 107(1). 194–195. 3 indexed citations

11.

Steed, Paul M., et al.. (1998). Characterization of recombinant human cathepsin B expressed at high levels in baculovirus. Protein Science. 7(9). 2033–2037. 10 indexed citations

12.

Steed, Paul M., Kirk Clark, William C. Boyar, & Daniel LaSala. (1998). Characterization of human PLD2 and the analysis of PLD isoform splice variants. The FASEB Journal. 12(13). 1309–1317. 103 indexed citations

13.

Burley, S.K., Xiaoling Xie, Kirk Clark, & Fong Shu. (1997). Histone-like transcription factors in eukaryotes. Current Opinion in Structural Biology. 7(1). 94–102. 44 indexed citations

14.

Clark, Kirk, E.D. Halay, Eseng Lai, & S.K. Burley. (1993). Co-crystal structure of the HNF-3/fork head DNA-recognition motif resembles histone H5. Nature. 364(6436). 412–420. 1086 indexed citations breakdown →

15.

Huang, Jenq‐Kuen, et al.. (1989). Nucleotide and predicted amino acid sequences of two different genes for high-pI ?-amylases from barley. Plant Molecular Biology. 12(1). 119–121. 23 indexed citations

16.

Grange, John M. & Kirk Clark. (1977). Use of umbelliferone derivatives in the study of enzyme activities of mycobacteria.. Journal of Clinical Pathology. 30(2). 151–153. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact